(MedPage Today) — NEW ORLEANS — A direct oral anticoagulant (DOAC) was unable to further lower the risk of atrial fibrillation (Afib or AF) patients a year or more after successful catheter ablation, according to the OCEAN trialists.
Altogether…
Source link : https://www.medpagetoday.com/meetingcoverage/aha/118392
Author :
Publish date : 2025-11-08 21:44:00
Copyright for syndicated content belongs to the linked Source.
